6Kimura Y, Aoki J, Kohno M, et al. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel[J]. Cancer Chemother Pharmacol, 2002, 49(4):322-328.
7Gilles Klopman, Leming M, Avner Ramu. Quantitative structure-activity relationship of multidrug resistance reversal agents[J]. Mol Pharmacol, 1997, 52(2):323-334.
8Naoki Sugiyama, Fumihiko Akahoshi, Shigeki Kuwahara, et al. Synthesis and topical anti-inflammatory and Antiallergic activities of Antioxidant o-Aminophenol Derivatives[J]. J Med Chem, 1994, 37(13):1977-1982.
9Mass A J, Morganroth J, Cardiac effects of ebastine and other antihistiamines in humans[J]. Drug Saf, 2000, 22(3):214-216.
10Brik A, Tashkin D P, Gong H Jr, et al. Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma[J]. J Allergy Clin Immunol, 1987, 80(1):51-56.
